admin

RADNOR, Pa. and DUBLIN, Nov. 6, 2019 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR) and the National Institute of Bioprocessing Research and Training (NIBRT) today announced they are teaming up to address downstream bottlenecks in buffer preparation when producing monoclonal antibodies (mAbs). As part of the joint effort, Avantor® is providing in-line dilution systems for hands-on experience at NIBRT’s prestigious training and research facility dedicated to supporting the global bioprocessing industry. Avantor’s technology adds to NIBRT’s full complement of bioprocessing capabilities.

The growth of the BioHealth Capital Region (BHCR) and its position as a global biohealth cluster is a hot topic of discussion—often filtered through a broad, conceptual lens focused on big-picture trends, GEN publication rankings and widely discussed areas of industry need.

The development and growth of the BHCR is also a story that supports the life science boom in the region and is steeped in real estate development, communities of innovation, bricks and mortar, architectural plans, and construction management, as well as facility and lab design innovation.

Image: https://biobuzz.io

The Maryland Technology Development Corporation (TEDCO) held its inaugural Entrepreneur Expo in 2011. The first Expo attracted approximately 300 attendees. Three times that number descended on The Hotel at the University of Maryland for its 9th annual Entrepreneur Expo on October 29th.

Entrepreneurs, thought leaders, small business owners, angel and venture investors, federal and state economic development teams and university leaders from across Maryland, the Biohealth Capital Region (BHCR) and beyond gathered at the event to network, share ideas and showcase their programs, technologies and companies.

The Chesapeake Bay Area Chapter of ISPE has partnered with the Regional Manufacturing Institute of Maryland and the Montgomery County Executive’s Office to bring some vital state and local resources to our industry at a trade-show like event on November 8 at the Washington DC/Rockville Hilton Hotel from 7:30-11:00 a.m.  The event is targeted at manufacturing executives, HR, CFOs and Engineering & Facility managers from leading biotech, pharma, IT, defense, printing and other industry executives from Montgomery County.  Please join us and find out how you can access thousands of dollars of state and local resources and meet the experts for those programs to address your workforce needs, reduce energy expenses and find grant funding, access financing/tax credit programs and more….all in one place.

Former Howard County Executive Ken Ulman is known for his work with the University of Maryland, which hired him in 2014 to boost economic development in College Park.

Now, Montgomery County officials are hiring Ulman for a different task — luring the University System of Maryland and its flagship campus at College Park.

“We’ve had a lot of conversations with folks in the county about the desire to drive more higher education investment,” Ulman said in a phone interview on Tuesday. “Essentially, you have Montgomery County — an engine of innovation, a strong business community, but lacking a traditional four-year university.”

Image: Ken Ulman, a former Howard County executive and founder of the consulting firm Margrave Strategies. PHOTO VIA MARGRAVE STRATEGIES

Earlier this year, Crunchbase, a database that tracks startup companies and their investors, noted that biotech venture funding has been increasing in recent years, with corporate venture investors significantly increasing their funding into biotechs in 2018. Recently, The San Francisco Business Times pulled together a list of the Bay Area’s top-funded biotech companies from July 1, 2018 through June 30, 2019. Here’s a look at the top 10.

“The Biggest Biotech Bombshell in Years,” declared The Motley Fool of Biogen’s market-moving announcement October 22 that it was planning to file for FDA approval of the Alzheimer’s disease (AD) candidate aducanumab, being co-developed with Eisai, despite halting two failed Phase III studies of the drug in March. Investors flocked to Biogen stock, sending the company’s stock price surging 40% before the start of trading that day. When the market closed, Biogen shares finished the day 26% higher at $281.87.

The Centers for Medicare and Medicare Services this week announced the 25 participants selected to move on to the next round of its Artificial Intelligence Health Outcomes Challenge.

WHY IT MATTERS

Launched this past March by the CMS Innovation Center, in collaboration with the American Academy of Family Physicians and the Laura and John Arnold Foundation, the AI Health Outcomes Challenge aims to give innovators a showcase for how they’re developing AI and machine learning technologies, deep learning tools and neural networks.

NEW YORK (Reuters) – As a private investor, former U.S. Food and Drug Administration Commissioner Scott Gottlieb is focused on an area where few have found success in recent years: developing new antibiotics.

Since leaving the FDA in April, Gottlieb has revealed little about what types of investments he would make in his new role at New Enterprise Associates, one of the country’s largest venture capital firms where he worked prior to his time in government.

Image: FILE PHOTO: FDA Commissioner Scott Gottlieb speaks during an interview with Reuters in New York City, U.S., November 26, 2018. REUTERS/Brendan McDermid/File Photo -https://www.reuters.com